Selective induction of cytochrome P450 isozymes in rat liver by 4-n-alkyl-methylenedioxybenzenes

Craig B. Marcus, Neil M. Wilson, Colin R. Jefcoate, Christopher F. Wilkinson, Curtis John Omiecinski

Research output: Contribution to journalArticle

28 Citations (Scopus)

Abstract

To examine the structural requirements of cytochrome P450 induction by 4-n-alkyl-substituted methylenedioxybenzenes (MDBs), rats were treated in vivo with a series of MDBs that differed in alkyl carbon sidechain length (0, 1, 2, 3, 4, 5, 6, or 8). Expression patterns of specific P450 isozymes were evaluated with Western and Northern blotting, enzymatic assays, and solution hybridization assays. As determined by carbon monoxide difference spectroscopy, maximal hepatic induction of total P450 content occurred when rats were treated with MDB derivatives with alkyl chain lengths of five or six carbons. However, maximum induction of the specific P450s-P450IA1, P450IIB1, and P450IIB2-occurred with n-hexyl-MDB. In contrast to effects observed with phenobarbital, treatment with MDBs resulted in higher levels of P450IIB2 than of P450IIB1 in rat hepatic microsomes. Western blot quantitation of MDB-induced hepatic P450IIB1 and P450IIB2 apoenzymes did not correlate to measured levels of the corresponding P450 mRNAs. In fact, P450IIB1 and P450IIB2 apoenzyme levels were consistently lower than expected based on Northern blot and solution hybridization measures of the respective mRNAs. These data suggest that the n-alkyl-MDBs effect increases in levels of hepatic P450 in a complex manner, producing accumulation of P450 mRNAs concomitant with alterations in processes regulating steady-state levels of P450 apoenzyme.

Original languageEnglish (US)
Pages (from-to)8-16
Number of pages9
JournalArchives of Biochemistry and Biophysics
Volume277
Issue number1
DOIs
StatePublished - Feb 15 1990

Fingerprint

Benzodioxoles
Liver
Cytochrome P-450 Enzyme System
Isoenzymes
Rats
Apoenzymes
Northern Blotting
Messenger RNA
Assays
Carbon
Western Blotting
Enzyme Assays
Carbon Monoxide
Phenobarbital
Microsomes
Chain length
Spectrum Analysis
Spectroscopy

All Science Journal Classification (ASJC) codes

  • Biophysics
  • Biochemistry
  • Molecular Biology

Cite this

Marcus, Craig B. ; Wilson, Neil M. ; Jefcoate, Colin R. ; Wilkinson, Christopher F. ; Omiecinski, Curtis John. / Selective induction of cytochrome P450 isozymes in rat liver by 4-n-alkyl-methylenedioxybenzenes. In: Archives of Biochemistry and Biophysics. 1990 ; Vol. 277, No. 1. pp. 8-16.
@article{e0f67a9123f44ebb8052455633a56fef,
title = "Selective induction of cytochrome P450 isozymes in rat liver by 4-n-alkyl-methylenedioxybenzenes",
abstract = "To examine the structural requirements of cytochrome P450 induction by 4-n-alkyl-substituted methylenedioxybenzenes (MDBs), rats were treated in vivo with a series of MDBs that differed in alkyl carbon sidechain length (0, 1, 2, 3, 4, 5, 6, or 8). Expression patterns of specific P450 isozymes were evaluated with Western and Northern blotting, enzymatic assays, and solution hybridization assays. As determined by carbon monoxide difference spectroscopy, maximal hepatic induction of total P450 content occurred when rats were treated with MDB derivatives with alkyl chain lengths of five or six carbons. However, maximum induction of the specific P450s-P450IA1, P450IIB1, and P450IIB2-occurred with n-hexyl-MDB. In contrast to effects observed with phenobarbital, treatment with MDBs resulted in higher levels of P450IIB2 than of P450IIB1 in rat hepatic microsomes. Western blot quantitation of MDB-induced hepatic P450IIB1 and P450IIB2 apoenzymes did not correlate to measured levels of the corresponding P450 mRNAs. In fact, P450IIB1 and P450IIB2 apoenzyme levels were consistently lower than expected based on Northern blot and solution hybridization measures of the respective mRNAs. These data suggest that the n-alkyl-MDBs effect increases in levels of hepatic P450 in a complex manner, producing accumulation of P450 mRNAs concomitant with alterations in processes regulating steady-state levels of P450 apoenzyme.",
author = "Marcus, {Craig B.} and Wilson, {Neil M.} and Jefcoate, {Colin R.} and Wilkinson, {Christopher F.} and Omiecinski, {Curtis John}",
year = "1990",
month = "2",
day = "15",
doi = "10.1016/0003-9861(90)90543-8",
language = "English (US)",
volume = "277",
pages = "8--16",
journal = "Archives of Biochemistry and Biophysics",
issn = "0003-9861",
publisher = "Academic Press Inc.",
number = "1",

}

Selective induction of cytochrome P450 isozymes in rat liver by 4-n-alkyl-methylenedioxybenzenes. / Marcus, Craig B.; Wilson, Neil M.; Jefcoate, Colin R.; Wilkinson, Christopher F.; Omiecinski, Curtis John.

In: Archives of Biochemistry and Biophysics, Vol. 277, No. 1, 15.02.1990, p. 8-16.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Selective induction of cytochrome P450 isozymes in rat liver by 4-n-alkyl-methylenedioxybenzenes

AU - Marcus, Craig B.

AU - Wilson, Neil M.

AU - Jefcoate, Colin R.

AU - Wilkinson, Christopher F.

AU - Omiecinski, Curtis John

PY - 1990/2/15

Y1 - 1990/2/15

N2 - To examine the structural requirements of cytochrome P450 induction by 4-n-alkyl-substituted methylenedioxybenzenes (MDBs), rats were treated in vivo with a series of MDBs that differed in alkyl carbon sidechain length (0, 1, 2, 3, 4, 5, 6, or 8). Expression patterns of specific P450 isozymes were evaluated with Western and Northern blotting, enzymatic assays, and solution hybridization assays. As determined by carbon monoxide difference spectroscopy, maximal hepatic induction of total P450 content occurred when rats were treated with MDB derivatives with alkyl chain lengths of five or six carbons. However, maximum induction of the specific P450s-P450IA1, P450IIB1, and P450IIB2-occurred with n-hexyl-MDB. In contrast to effects observed with phenobarbital, treatment with MDBs resulted in higher levels of P450IIB2 than of P450IIB1 in rat hepatic microsomes. Western blot quantitation of MDB-induced hepatic P450IIB1 and P450IIB2 apoenzymes did not correlate to measured levels of the corresponding P450 mRNAs. In fact, P450IIB1 and P450IIB2 apoenzyme levels were consistently lower than expected based on Northern blot and solution hybridization measures of the respective mRNAs. These data suggest that the n-alkyl-MDBs effect increases in levels of hepatic P450 in a complex manner, producing accumulation of P450 mRNAs concomitant with alterations in processes regulating steady-state levels of P450 apoenzyme.

AB - To examine the structural requirements of cytochrome P450 induction by 4-n-alkyl-substituted methylenedioxybenzenes (MDBs), rats were treated in vivo with a series of MDBs that differed in alkyl carbon sidechain length (0, 1, 2, 3, 4, 5, 6, or 8). Expression patterns of specific P450 isozymes were evaluated with Western and Northern blotting, enzymatic assays, and solution hybridization assays. As determined by carbon monoxide difference spectroscopy, maximal hepatic induction of total P450 content occurred when rats were treated with MDB derivatives with alkyl chain lengths of five or six carbons. However, maximum induction of the specific P450s-P450IA1, P450IIB1, and P450IIB2-occurred with n-hexyl-MDB. In contrast to effects observed with phenobarbital, treatment with MDBs resulted in higher levels of P450IIB2 than of P450IIB1 in rat hepatic microsomes. Western blot quantitation of MDB-induced hepatic P450IIB1 and P450IIB2 apoenzymes did not correlate to measured levels of the corresponding P450 mRNAs. In fact, P450IIB1 and P450IIB2 apoenzyme levels were consistently lower than expected based on Northern blot and solution hybridization measures of the respective mRNAs. These data suggest that the n-alkyl-MDBs effect increases in levels of hepatic P450 in a complex manner, producing accumulation of P450 mRNAs concomitant with alterations in processes regulating steady-state levels of P450 apoenzyme.

UR - http://www.scopus.com/inward/record.url?scp=0025156936&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025156936&partnerID=8YFLogxK

U2 - 10.1016/0003-9861(90)90543-8

DO - 10.1016/0003-9861(90)90543-8

M3 - Article

C2 - 2306127

AN - SCOPUS:0025156936

VL - 277

SP - 8

EP - 16

JO - Archives of Biochemistry and Biophysics

JF - Archives of Biochemistry and Biophysics

SN - 0003-9861

IS - 1

ER -